Search

everythinglearnresearchcommunity

for

Search:↓

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Tofacitinib may help treat hair loss in children with alopecia areata.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Platelet Rich Fibrin improves healing and reduces acne scars by slowly releasing growth factors.

17β-estradiol can reduce inflammation in the skin.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Clofazimine effectively treated ashy dermatosis in a patient.

Platelet-rich plasma helps tissue healing but lacks standard use methods.

Two patients with stubborn hair loss grew hair after PDRN injections.

PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.

Fluid Platelet-Rich Fibrin (PRF) is more effective and faster at improving acne scars than Platelet-Rich Plasma (PRP), with similar mild side effects.

PRP's effectiveness in healing is unclear and needs more research.

Pix Liquida may help treat alopecia areata.

PRP is a safe and effective treatment for hair loss.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

The treatment improved hair growth in three patients with alopecia.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

PRP treatments for hair loss need standard protocols to be reliable.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Platelet-rich plasma shows promise in healing and treating musculoskeletal issues, but translating lab results to human treatments is challenging.